The 6 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 6.50, with a high estimate of 15.00 and a low estimate of 5.00. The median estimate represents a +169.71% increase from the last price of 2.41.
The current consensus among 7 polled investment analysts is to Sell stock in Puma Biotechnology Inc. This rating has held steady since October, when it was unchanged from a Sell rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.10
Reporting Date Mar 03
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.